A systematic overview of radiation therapy effects in ovarian cancer

Acta Oncologica

Volumn 42, Issue 5-6, 2003, Pages 562-566

  Einhorn, Nina ^a   Tropé, Claes ^b   Ridderheim, Mona ^d   Boman, Karin ^d   Sorbe, Bengt ^c   Cavallin Ståhl, Eva ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Central Hospital of Örebro   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE; IRRADIATION; RADIOTHERAPY; TUMORS;

OVARIAN CANCERS;

ONCOLOGY;

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; MELPHALAN; PREDNIMUSTINE;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HIGH RISK POPULATION; HUMAN; MEDICAL LITERATURE; OVARY CARCINOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; WHOLE BODY RADIATION;

ADULT; AGED; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SALVAGE THERAPY; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 0141525461     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310014426     Document Type: Review

References (12)

1. Högberg T, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 2001; 40: 340-60.
2. Young R, MFB, Nieberg R, et al. Randomized clinical trial of adjuvant treatment of women with early (FIGO I-IIA high risk) ovarian cancer - GOG #95, Int J Gynecol Cancer 1999; 9: 11, Abstr. A33.
3. Bolis G, Colombo N, Pecorelli S, et al. Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). GICOG: Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Ann Oncol 1995; 6: 887-93.
4. Dent SF, Klaassen D, Pater JL, et al. Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG). Ann Oncol 2000; 11: 65-8.
5. Chiara S, Conte P, Franzone P, et al. High-risk early-stage ovarian cancer. Randomized clinical trial comparing cisplatin plus cyclophosphamide versus whole abdominal radiotherapy. Am J Clin Oncol 1994; 17: 72-6.
6. Sorbe B. Consolidation treatment of ovarian carcinoma, stage III, at complete surgical remission after induction chemotherapy. Int J Gynecol Cancer 2003; 13: 278-86.
7. Einhorn N, Lundell M, Nilsson B, et al. Is there place for radiotherapy in the treatment of advanced ovarian cancer? Radiother Oncol 1999; 53: 213-8.
8. Pickel H, Lahousen M, Petru E, et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 1999; 72: 215-9.
9. Kaldor JM, Day NE, Kittelmann B, et al. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 1995; 63: 1-6.
10. Fyles AW, Thomas GM, Pintilie M, et al. A randomized study of two doses of abdominopelvic radiation therapy for patients with optimally debulked Stage I, II, and III ovarian cancer. Int J Radiat Oncol Biol Phys 1998; 41: 543-9.
11. Nicholson S, Gooden CS, Hird V, et al. Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis. Oncol Rep 1998; 5: 223-6.
12. Gelblum D, Mychalczak B, Almadrones L, et al. Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma. Gynecol Oncol 1998; 69: 36-41.